As of 2026-05-26, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (460.72) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -111.9%.
The range of the Relative Valuation is (456.80) - (488.66) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 20.0x | 19.4x |
| Forward P/E multiples | 16.6x - 19.9x | 18.2x |
| Fair Price | (456.80) - (488.66) | (460.72) |
| Upside | -111.8% - -112.6% | -111.9% |
| Date | P/E |